Clinical Trial Update: HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

View source ↗

Summary

A clinical trial update indicates a study evaluating a therapy for HER2-low unresectable and/or metastatic breast cancer in Russia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED